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Hanging in the balance: natural killer cell 
recognition of target cells 
Natural killer (NK) cells kill certain tumor cells and virus-infected cells directly. Until 
recently, little was known about how they recognize their targets. Now, several 
candidate NK receptors have been identified, some of which may have carbohydrate 
ligands. Some of the receptors deliver positive signals, others negative signals. Thus 
NK cells seem to balance many different inputs to decide whether to kill a target. 
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Natural killer (NK) cells are a population of lymphocytes 
that have the inherent capacity to kill certain tumor cells 
and virus-infected cells. For many years, little was known 
about how NK cells recognize and interact with their 
specific targets. Recently, there have been dramatic and 
fundamental changes in our understanding of how NK 
cells recognize target cells. Indeed, the problem is no 
longer that we lack candidate NK receptors, but that we 
seem to have too many of them. 
In general, the newly described molecules that modulate 
NK function appear to segregate into two basic cate- 
gories: those that activate lysis and those that inhibit it. 
This is an oversimplification, however, as some appear to 
do both in different circumstances. Some of the candi- 
date receptors bind to class I molecules of the major his- 
tocompatibility complex (MHC), and generally deliver 
negative signals to the NK cell; others bind to poorly 
characterized target cell receptors and deliver positive 
signals. Several of these receptors, of both the negative 
and positive signaling types, are C-type lectins and would 
thus be expected to recognize carbohydrate ligands in a 
Ca2+-dependent manner. Here we summarize the recent 
progress in defining NK interactions with target cells. 
For convenience, we separate the receptors that appear to 
deliver negative signals, in general, from those that seem 
generally to deliver positive signals. Both may be impor- 
tant in NK recognition; an NK cell may balance several 
positive signals against negative ones to determine the 
outcome of an interaction with a given target cell [l]. 
Turn-offs: NK cell receptors binding to MHC class I molecules 
It has long been known that expression of class I mole- 
cules from the major histocompatibility complex 
(MHC) can protect target cells against NK-mediated 
lysis. The initial observation was that a lack of class I 
expression on target cells increased the susceptibility to 
NK killing (reviewed in [2] and [3]). Two possible 
mechanisms for this phenomenon have been put 
forward. First, recognition of class I may turn off the 
lytic capacity of the NK cell. Thus, normal cells, which 
should not be targets for NK lysis, would be protected 
from NK killing by the expression of appropriate (or 
‘self’) class I MHC molecules. However, tumors or 
virus-infected cells may lose or reduce their expression 
of class I MHC to avoid lysis by CTLs. Such cells would 
be lysed by NK cells since they fail to deliver a negative 
signal [2].Alternatively, class I MHC may not be recog- 
nized by NK cells directly, but may hide or block access 
to a ligand bound by NK cell receptors [2]. Loss of class 
I MHC would thus allow recognition of the putative 
ligand, causing the target to be lysed. 
Recent developments strongly suggest that the first 
hypothesis is correct.There are now several well charac- 
terized NK cell receptors that bind to specific class I 
molecules and inactivate the NK cell (summarized in 
Table l).These are discussed in more detail below. 
Ly49s - lectins that recognize class I MHC 
Ly49s are dimeric,Type II glycoproteins belonging to the 
C-type lectin superfamily [4,5]. Two other families of 
NK cell specific proteins, the NKR-Pls, which also 
appear to be NK receptors (see below) and the NKG2s, 
of unknown function, are also C-type lectins. These 
three protein families have been classed together as 
GroupV of the C-type lectins [5]. 
To date, eight genes encoding Ly49s have been identi- 
fied in the mouse (Ly49A-H) [4,6-S], and three 
members of this gene family have been cloned in the rat 
(J. Ryan and W.E. Seaman, personal communication). 
No human homologs of Ly49s have yet been reported. 
Expression of one member of the Ly49 family probably 
does not preclude the expression of others; it is known, 
for example, that Ly49A and Ly49C can be co-expressed 
[9]. These lectin molecules appear to recognize class I 
MHC. The importance of carbohydrate in recognition is 
discussed below. 
Class I MHC molecules are polymorphic.There are three 
main loci encoding these molecules in both mouse and 
human, with up to 70 different alleles at each locus. 
Different members of the Ly49 family appear to bind dif- 
ferent subsets of class I MHC molecules. For example, 
murine Ly49A binds to the murine class I MHC mole- 
cule H-2Dd, and NK cells that express Ly49A cannot 
lyse target cells that express H-2Dd [lo-131. Indeed, 
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interactions between Ly49A and H-2Dd may inactivate 
NK cells completely. As well as recognizing their targets 
via specialized and poorly understood mechanisms, NK 
cells can also use a more general mechanism to destroy 
targets that are coated with antibody, in a reaction called 
antibody-dependent cellular cytotoxicity (ADCC). 
Ly49A+ NK cells are also unable to mediate ADCC 
against target cells carrying H-2Dd, suggesting that the 
presence of H-2Dd does not simply prevent the recogni- 
tion of the target [lo, 131. Binding of a Ly49 molecule to a 
class I MHC molecule does not seem to be the only 
requirement for inactivation, however. Ly49A also binds 
to a second class I MHC molecule, H-2Kb, with an affin- 
ity comparable to that for H-2Dd [ll]: but H-2Kb does 
not protect a target cell from lysis [lO,13]. It will be of 
considerable interest to determine which MHC class I 
molecules are recognized by which members of the Ly49 
family, and which of these interactions inactivate NK cells. 
Although, in general, most Ly49 molecules appear to inac- 
tivate NK cell lysis, some may deliver activating signals. 
For instance, there is some evidence that cross-linking of 
Ly49D or Ly49C triggers NK lysis [14,15]. 
p58s/NKATs - receptor candidates from the 
immunoglobulin superfamily 
Human NK cells express at least two 58-kDa molecules 
(~58) that appear to interact with human class I MHC 
molecule of the HLA-C alleles. These appear to inhibit 
NK lysis [16,17], although, again, certain p58 molecules 
may activate NK function. Recently, several p58 mole- 
cules have been independently cloned by two groups 
[18,19]. These molecules are part of a new NK gene 
family provisionally termed NKAT (NK-associated 
transcripts) [1X], which may have as many as six 
members. These putative NK receptors belong to the 
immunoglobulin superfamily, and are unrelated to the 
C-type lectins. Thus, disparate types of NK receptors 
may interact with class I MHC molecules, with similar 
functional consequences. 
Using NK cell-specific monoclonal antibodies, a mole- 
cule known as NKBl has recently been identified that 
recognizes the Bw4 epitope of several forms of the 
human class I MHC molecule HLA-B.This interaction 
results in a loss of lytic function [20,21]. Sequence data 
on NKBl are not available, but as the NKAT3 and 
NKAT4 genes encode molecules with the same molecu- 
lar mass as deglycosylated NKBl protein, and also appear 
to recognize Bw4, it seems likely that NKBl will prove 
to be encoded by NKAT3 and/or NKAT4. 
CD94 (Kp43) - a window onto signaling 
CD94 (Kp43) is a 70-kDa disulfide-linked dimer 
expressed on human NK cells and certain subsets of T 
lymphocytes [22]. CD94 has recently been cloned, and 
found to be a member of the C-type lectin superfamily 
although it is not a Ly49 homolog [23]. It recognizes the 
class I MHC molecules HLA-B7, -B8, -B14 and -B27 
1241. Crosslinking of CD94 transduces signals resulting in 
Table 1. Class I MHC-NK cell receptor interactions that result in loss of NK cell lysis of target cellsa 
NK cell receptor 
Human 
NKBI 
H LA-A 
- 
Class I MHC reactivity 
HLA-B 
B*1513b 
B*2403 
B*2501 
B*2705 
B*5101 
B*5801 
HLA-C 
- 
~58 - cw*3 
NKAT-1 cw*o401 
Cw’l503 
CD94 B7 
B8 
B14 
B27 
Mouse H-2b H-2d H-2k H-2P H-2‘-J H-2’ H-2S 
Ly49A + (K) + 0) -c 0) 
Ly49C‘ + + + + 
aThe class I MHC alleles recognized by the different NK receptor candidates are listed. In the mouse, it is often not known which class 
I gene product is recognized; instead, what is known is that one of the three class I molecules of a particular strain can be recognized. 
For Ly49A the specific class I MHC molecules recognized are known, and are noted in parentheses. 
bAll HLA-B molecules recognized by NKBI contain the Bw4 epitope. 
CNot determined if binding results in protection from NK lysis. 
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phospholipase D activation and release of TNF-a, but 
does not induce Ca”+ mobilization or phosphatidyl- 
inositol hydrolysis, two events commonly associated with 
receptor-mediated cell signaling [25].There are some NK 
clones, however, in which lysis is activated, not inhibited, 
by CD94 crosslinking; in these cells, intracellular Ca2+ 
levels do rise. Thus, it may be possible to identify the 
point at which the positive and negative signaling path- 
ways diverge by comparing NK clones that have different 
responses to CD94 crosslinking. 
Structural requirements for NK recognition of MHC class I 
The class I MHC molecule is composed of a polymor- 
phic heavy chain complexed noncovalently with an 
invariant B2-microglobulin (P2m) light chain. The 
heavy chain contains sites for N-linked glycosylation 
(one site in humans, two in mice) and a ‘groove’, defined 
by two o-helices (al and a2), in which peptides that 
are processed from proteins made within the cell are 
presented [26,27]. Since some of the class-I-specific 
receptors on NK cells belong to the C-type lectin 
family, it is of obvious interest to determine whether 
recognition of class I involves oligosaccharide binding, 
and if so, by which receptors. Further, it is of interest to 
determine whether the specific peptide bound to class I 
affects NK recognition. It is known that T-cell recep- 
tor/class I interactions are exquisitely specific for pep- 
tides presented by class I, but much less is known about 
whether NK receptors are similarly affected. 
A limited amount of work has been done towards deter- 
mining whether specific carbohydrate expression is 
required for NK recognition of class I MHC. Early work 
done with bulk populations of fresh NK cells demon- 
strated that carbohydrate expression was not required for 
class I to inhibit NK lysis [as]. However, now that it has 
become clear that multiple receptors with different 
targets exist, it is no longer enough to study the behav- 
ior of a bulk NK population; we must ask, instead, 
whether the function of individual NK clones or NK 
receptors is oligosaccharide-dependent. Recently, 
Gumperz ct al. [21] determined that oligosaccharides 
were not of significance for inactivation of NK clones 
carrying the NKBI receptor by HLA-Bw4+ target cells. 
Thus, the NKBl receptor does not appear to recognize 
carbohydrate moieties expressed on class I MHC. 
However, as discussed above, NKBl is suspected to be a 
member of the immunoglobulin superfamily and there- 
fore would not be expected to recognize carbohydrate. 
In contrast, the Ly49 C-type lectins examined to date do 
appear to recognize carbohydrates, although it is not yet 
known if this is important in the physiological response 
of NK cells to class I MHC-bearing target cells. Ly49A 
has a functional lectin domain and binds fucoidan [29]. 
Some complex N-linked glycans expressed on class I 
contain fucose [27] and these might serve as ligands for 
Ly49A, but it has not been directly determined whether 
the binding of Ly49A to class I is dependent upon an 
associated oligosaccharide. Interestingly, Ly49C also 
appears to bind fucose, since binding of Ly49C to class I 
MHC has been found to be inhibited by fucoidan and 
by fucosidase treatment [9]. 
Since the carbohydrate recognition domains of Ly49A 
and Ly49C have only -50% homology, it is somewhat 
surprising that they have such similar specificities. To 
accomodate these data, Brennan et al. [9] have postu- 
lated that Ly49s may recognize class I MHC as a combi- 
nation of a carbohydrate moiety and associated protein. 
It is similarly speculated that the L- and P-selectins bind 
to a combination of carbohydrate and protein [30]. It 
has been shown that there is heterogeneity in the 
oligosaccharide moieties expressed on different class I 
molecules 1271. This leaves open the possibility that 
other members of the Ly49 family (or perhaps other 
NK-expressed C-type lectins) may bind class I in the 
context of different carbohydrates. 
Cell-surface class I MHC molecules generally carry pep- 
tides in their peptide-binding groove 1261. The peptide 
forms an essential part of the complex recognized by the 
T-cell receptor. It is, therefore, of significant interest to 
determine if the peptide is also involved in NK receptor 
interactions with class I MHC. Several observations 
suggest that peptides may be important. Early studies 
determined that expression of both the aI and (r2 
domains were required for protection against NK medi- 
ated killing, suggesting that an intact peptide-binding 
cleft is necessary [2X]. By extrapolation, it could be 
inferred that peptide itself might affect NK recognition. 
This could occur in two ways: first, peptide may confer a 
required conformation to the class I molecule; or, 
second, the identity of the individual peptide itself may 
be important. The situation is complicated, however, by 
the fact that peptides are required to stabilize the class I 
MHC molecule, so that class I molecules that lack 
peptide are poorly transported to the cell surface and 
have a short half-life once there. 
Malnati et al. 1311 reported data supporting the possi- 
bility that specific peptides might be recognized by 
NK cells.They observed that human NK clones inhib- 
ited by the class I MHC molecule HLA-B27 were dif- 
ferentially sensitive to single amino acid substitutions 
in the peptide-binding site of HLA-B27. Such substi- 
tutions may alter the repertoire of peptides that can 
bind to the peptide-binding site. More importantly, 
these clones were also differentially inhibited depend- 
ing on which specific peptide was presented. In this 
system, however, the receptor used by the NK cell was 
not defined. In contrast, Correa and Raulet [33] 
demonstrated, in the murine system, that virtually any 
peptide presented by H-2Dd was sufficient to inacti- 
vate Ly49A+ NK cells, as long as the peptide allowed 
high levels of class I expression. 
The reasons for the differences in the results regarding 
peptide specificity in these two models are not yet clear. 
Many factors may affect these results, including species 
differences, the use of heterogeneous populations of cells, 
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differences in affinity of the various peptides for class I, or 
differences in the receptor that is used for recognition. 
Perhaps the specificity of Ly-49 binding is dependent only 
on carbohydrate, not peptide, and peptide is only impor- 
tant to ensure high levels of class I MHC expression on 
the surface of the cell. It is also plausible that the human 
NK receptor recognizing HLA-B27 is NKBl. We have 
already argued that NKBl may be a member of the 
immunoglobulin superfamily and not a C-type lectin 
[20,21]. It is not unreasonable to think that NK receptors 
belonging to the immunoglobulin superfamily (to which 
the T-cell receptor belongs) might be somewhat similar to 
the T-cell receptor in their specificity, binding to a molec- 
ular complex that is partially composed of peptide. 
Clearly, resolving the role of peptide in NK recognition 
will be of fundamental importance for understanding how 
class I MHC modulates target cell susceptibility. 
Turn-ons: NK cell receptors for target cell ligands 
There is a growing number of candidate receptors that 
may activate NK cells in response to target cells. In 
defining such receptors, several aspects of NK cell 
biology must be kept in mind. There is no evidence for 
DNA recombination in NK cells, unlike the situation in 
T-cells or antibody-producing cells. This statement is 
based largely on the observation that NK cells develop 
and function normally in SCID and RAG-deficient 
mice [33,34], which lack the mechanisms required for 
recombination of T-cell receptor and antibody genes. 
Furthermore, clones of NK cells do not have fine speci- 
ficity, as different clones recognize multiple types of 
targets [35] .Although the number of NK receptors listed 
in this article may seem large, the number pales in com- 
parison with the vast repertoire of specificities that are 
generated by combinatorial rearrangement in T-cells and 
antibody-producing cells. How, then, is differential 
recognition of target cells by NK clones acheived? 
It has been suggested that NK recognition involves the 
coordinated interaction of a number of receptors providing 
activation signals. It is important to distinguish between 
receptor-ligand interactions that increase lysis, and those 
that contribute to specificity; for example, it is clear that 
certain adhesion molecules such as LFA-1 and CD2 con- 
tribute to the conjugation of NK cells to target cells, and 
may promote NK cell activation [36]. But it is apparent 
that molecules of this type do not contribute to the selec- 
tivity of NK recognition, and instead enhance lysis trig- 
gered by other receptors.The selectivity is likely to reflect 
how many of the receptors on a particular NK cell match 
the ligands available on a target cell. As described above, 
some NK selectivity may be due to ‘turning off’ the NK 
cell. But it is obvious that NK cells must also have recep- 
tors that activate lysis of appropriate targets as there is some 
selectivity in their target cell preference. A number of 
candidate receptors of this type have recently been defined. 
NKR-Pl s - lectin ‘turn-ons’ 
Among the first activating NK receptors to be identified 
were the NKR-Pls; these are dimeric, 60-80-kDa signal 
transduction molecules that are members of the C-type 
lectin superfamily [37,38]. There are three mouse NKR- 
Pl genes [39,40], and probably five in the rat (J. Ryan 
and W.E. Seaman, personal communication; PM. 
Appasamy and W.H.C., unpublished data). Only one 
human NKR-Pl homolog has been reported so far [41]. 
Although there are some species differences, in general 
NKR-Pls are expressed on essentially all NK cells and 
some T-cells [41-431. Most of the available data indicate 
that NKR-Pls are involved in activation of NK cells 
[37,38,44]. However, as with the class I binding mole- 
cules, there is evidence to suggest that they can also 
deliver inactivating signals [41,45]. 
Rat NKR-PlA (rNKR-PlA) has been reported to bind 
neoglycoproteins expressing amino sugars (e.g., N- 
acetylgalactosamine), in a Ca2+-dependent manner, with 
very high affinity [46,47]. Soluble rNKR-PlA also binds 
to multiple target cell associated oligosaccharides, partic- 
ularly chondroitin sulfate glycosaminoglycans [47]. The 
NK cell line RNK-16 responds to YAC-1 target cells 
with increases in intracellular Ca’+ and the production 
of inositol phosphates.These responses were inhibited by 
soluble rNKR-Pl [47], suggesting that the interaction of 
NKR-Pl with oligosaccharides on target cells may be 
involved in activatingYAC-1 lysis.The interesting ques- 
tion of whether different members of the NKR-Pl 
gene family have different oligosaccharide-binding 
characteristics remains to be addressed. 
Once again, the situation is far from clear. In one study, 
mutant clones of the rat RNK-16 cell line which lack 
expression of ,a11 NKR-Pls could still efficiently lyse 
YAC-1 targets,,bt$ were deficient in lysing a different 
target cell line, IC-21 [48]. Re-expression of NKR-PlA 
in the NKR-Pl deficient cells partially restored their 
ability to lyse IC-21, suggesting that NKR-Pl was 
involved in killing of IC-21. In another study, some 
rat NK clones spontaneously lost expression of all 
NKR-Pls, but maintained the ability to lyseYAC-1 and 
IC-21 target cells [49].The discrepancies between these 
studies indicate that much additional work needs to be 
done before the physiological functions and ligands of 
NKR-Pl are understood. 
NK-TRI - a non-lectin receptor with a carbohydrate ligand 
The identification of NK-TRl was unusual. The classic 
human NK cell target, K562, carries a carbohydrate 
epitope, which is thought to be involved in NK recogni- 
tion of this cell line.To identify the receptors that bind to 
carbohydrates, an anti-idiotype (anti-id) antiserum was 
raised against a monoclonal antibody that recognizes this 
epitope [50]. Since the monoclonal antibody and the 
putative NK receptor are similar in that they bind the 
carbohydrate epitope, it was hoped that the anti-id would 
recognize the NK cell receptor as well as the monoclonal 
antibody.The anti-id indeed recognized NK cell associ- 
ated proteins of 150 and 80 kD [SO]. Subsequently, an 
NK-TRl-specific cDNA was isolated and found 
to encode a unique 150 kD protein containing a 
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cyclophilin-like domain [ 5 I]. Although NK-TR 1 is 
b&wed to recognize JD oligosaccharide, there is no 
C\ppxent (I- or S-type lcctin domain in NK-TRI 
The first evidence that NK-TR 1 \vas J ‘turn-on’ recep- 
tor came from the observation that blocking NK-TR 1 
inhibited NK cell lycis of K562, while cross-linking of 
NK-TR1 ,lctwated NK lytic activity [SO]. More recently, 
it mm reported that trmsfecting the RKN 16 cell line 
m-it11 JII mtisensc copy of the RNA for NK-TR 1 dra- 
matically reduced the lcvcls of lysis of NK-sensitive 
urgetc end Ihui,ria virus infected cells. Ho\vevcr, there 
\\-a~ no effect on ,lntihody-dependent lysis IS?]. These 
d.lt,l ~11 strongly sugscst a role for NK-TRl in NK cell 
interxtions \\+th tunlor cells such AS YAC:-1 cells, and, 
interestingly. \\ith viruc-infected cells. 
2B4s - turn-ons from the immunoglobulin superfamily 
334, a 06 kl) 1110110111er txpressed on all NK cells md on 
T-cells that show NK-like cytotosicity in mice, appears 
to be iniportmt in actiKiting the lytic machinery of these 
cells [.i3.SJ] .The exprmion of 2B-l in mouse strains cor- 
respond\ to the expression of NKII-1’1s [X5,9], but it is 
not kno\\m if 213-l JIICI NKl<-PI s may somehow act in 
concert. 2134 is d no\-el meiiiber of the Ig super~twe 
fmdy, \vith somt homology to 11u1nan LFA-3 mc1 r,lt 
CIUX; there are s~vtml closely-related 2B-l genes ISS]. 
Although no lignnd for 3B+ has yet been reported, the 
data av&ble strongly suggest that thrse molecules x-e a11 
important element of the NK cell recognition repertoire. 
p38 - a new entry in the lists 
The latest candid.lte receptor for activation of NK cells, 
p38, h.ls recently been defined using biochemical and 
mtibod~~ data [.X1. but has not yet been cloned. 
Antibody to p.?H acti\atcs a variety of NK cell functions 
including cytotosicity, Cl’+ mobilization, rind produc- 
tion of interferons. but, curiously, does not induce 
granule esocvtosis I.%]. Blocking p3X inhibits the lysis of 
tunlor target cells by freshly isolated NK cells; ~38 nlay 
also be important in the xtlvlty of T-cells that mediate 
nm-MHC restrict& cytotosicity 1X5]. 
Summary 
SignifGx~t :ldvanccs have been made in defining NK 
ccl1 receptors involved in the recognition of tumors or 
virus-infected target cells (Fig. 1). It ig now clear that 
NK cells have man); ~vays to recognize class I MHC 
lllolecules, and that these receptors directly deliver 
signals that inhibit lytic f6nction.The rrdundnncy in this 
protecti\-e eff&X, :iind the f,ict that Gniilar negative sigmils 
arc medi,ltcd by highly dispxlte molecules, is striking. 
Activate lysis: 
/ 
Monomer type I 1?1:pi8 
ivlonomrr, rvpe I, lg supergene 
/ /- family: 2B4 
Monomer, type I: NK-TRI Activate lysis: 
NK-TRl ligand, 
N-Linked glycan 
Proteoglycdn, U-lbnlted 
glycosaminnglycnns 
inactivate lysis: 
Homodimer, type I: p5WNKATl 
Monomer, type I(?): NKB I i Inactivate lysis: 
class I MHC/P2r 
Dlmeric, type II, C-type 
L lectins: Ly495, CD94 I!) 
heterotrimcr 
a: Chemistry & 
n/peptide 
Rioloev, 1995 
Fig. 1. NK activation is a product of many recognition steps, some of which send positive signals, others of which send negative signals. 
The NK receptors and target cell ligmds discovered to date arc summarized here. Many receptors can deliver both positive and nega- 
tive signals (see texti; the signal shown here is the signal that appears to he dominant for each receptor. 
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These results underscore the importance of preventing 
NK cells from attacking normal cells. Since NK cells are 
actively lytic without apparent prior sensitization, they 
would seem to be in a continual state of readiness to 
destroy target cells.Thus, it is crucial to provide redun- 
dant mechanisms for controlling reactivity against 
normal self. 
The ability of NK cells to react against ‘missing self’ (i.e. 
lack of class I) in general, rather than against specific 
foreign antigen, fits teleologically with what is known of 
NK biology. Cytotoxic T-cells primarily recognize viral 
peptides presented in the binding groove of class I MHC 
molecules; to recognize all the possible varieties of invad- 
ing viruses, T-cells require a vast repertoire of receptors, 
too large to be encoded in the genome, which is gener- 
ated by DNA rearrangement. But T-cells, despite their 
power, have an Achilles’ heel - if a virus should manage 
to prevent class I MHC expression on the surface of its 
host cell, the T-cell would have nothing to recognize. NK 
cells provide a crucial fail-safe mechanism for the 
immune system by recognizing cells that have lost class I 
MHC expression. 
It is not yet clear whether the NK cells present in a 
given animal are selected to be unable to recognize the 
cells in that animal.T-cells that react with the combina- 
tion of class I MHC with self peptide are eliminated 
early in their development; it is unclear whether NK 
cells follow a similar pattern. There is some evidence, 
however, that the expression of a specific class I MHC 
allele in a .strain of mice affects either the number of 
Ly49-expressing cells, or the level of Ly49 expressed 
[57,58]. Additional experimentation will be necessary 
before it is clear whether this is correct. Any notion of 
NK cell selection must also be reconciled with the data 
suggesting that some of the class I-specific NK receptors 
(e.g. CD94) may be ambivalent in function. 
It is also possible that NK cells undergo some form of 
positive selection. T-cells appear to be positively selected 
(for the ability to recognize the particular features of ‘self’ 
MHC) before the step of negative selection (in which T- 
cells that bind too tightly to the combination of self 
MHC with self peptide die). If NK cells are positively 
selected, one would predict that NK receptors that recog- 
nize class I MHC should be able to send positive signals 
as well as negative signals, at least at some stage of NK cell 
development. As we have noted above, there is indeed 
evidence that some receptors that bind to class I MHC 
can send positive signals, despite the general perception 
that NK cells recognize targets that lack class I MHC. In 
this context, it is interesting that NK cells from class-I- 
deficient mice seem to be less lytically efficient than NK 
cells from normal mice [59]. Furthermore, NK cells that 
reject B6 marrow develop in B6 animals transgenic for 
foreign class I [60]. This suggests that the foreign class I 
molecule induced the development of NK cells which 
recognize (and are turned off by) this molecule, and 
therefore perceive the normal B6 cells as lacking self. 
In addition to the negative regulatory receptors that 
influence NK cell recognition, there are now clearly 
defined receptorsand multigene familes of receptors, that 
seem to be able to activate NK cells. Some of these 
receptors, for example, NKR-Pl and NK-TRl, may 
recognize oligosaccharide determinants on target cells. In 
general, however, very little is known about the nature of 
the ligands that interact with NK-activating molecules. It 
could be speculated that some will be conserved mole- 
cules, since NK cells of different species are similar in 
function and can recognize targets across species barriers. 
Many additional experiments will be necessary to clarify 
what the true ligands for NK cells are and how these 
affect NK activity. 
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